7 Recruiting Melanoma Clinical Trials in Arizona
Explore active melanoma research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Melanoma Studies in Arizona
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)
📍 University of Arizona — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
📍 Local Institution - 0125 — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase4 💊 Investigational Drug / Biologic
Dabrafenib and/or Trametinib Rollover Study
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
📍 Local Institution - 0010 — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
📍 Arizona Cancer Center at UMC North/University Medical Center — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
📍 University of Arizona Cancer Center ( Site 0121) — Tucson, Arizona
View Study & Checklist ➔